Predictive Value of SYN-1 Levels for Mortality in Sepsis Patients in the Emergency Department
Le Hu,Jia Wang,Ye Zhang,Junyu Wang,Bing Wei
DOI: https://doi.org/10.2147/jir.s468763
IF: 4.5
2024-11-28
Journal of Inflammation Research
Abstract:Le Hu, 1– 3 Jia Wang, 1– 3 Ye Zhang, 1– 3 Junyu Wang, 1– 3 Bing Wei 1– 3 1 Emergency Medical Center, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People's Republic of China; 2 Beijing Key Laboratory of Cardiopulmonary Cerebral Resuscitation, Beijing, People's Republic of China; 3 Clinical Center for Medicine in Acute Infection, Capital Medical University, Beijing, People's Republic of China Correspondence: Bing Wei; Junyu Wang, Email ; Objective: To evaluate and predict adverse outcomes associated with serum Syndecan-1 (SYN-1) levels in patients with early sepsis, and to explore the prognostic risk factors in sepsis and septic shock. Methods: This retrospective single-center observational study included 168 sepsis patients admitted to the Emergency Department of Beijing Chao-Yang Hospital Shijingshan Branch, Capital Medical University, from October 2020 to October 2021. Patients were categorized into sepsis (n=114) and septic shock (n=54) groups based on Sepsis 3.0 criteria. They were further divided into survival (n=128) and death (n=40) groups. Comparative analyses included general demographics and laboratory findings (SYN-1, lactic acid [LAC], procalcitonin [PCT], C-reactive protein [CRP]) within 3 hours of admission, as well as Acute Physiology and Chronic Health Evaluation II (APACHE II) and Sequential Organ Failure Assessment (SOFA) scores. Statistical methods included receiver operating characteristic (ROC) curve analysis, correlation analysis, and logistic regression. Results: Serum SYN-1 levels were significantly higher in the septic shock group (138.89± 9.26) compared to the sepsis group (102.89± 8.97) (P < 0.05). SYN-1 levels were also significantly higher in the death group (150.19± 7.65) compared to the survival group (103.301± 86.59) (P < 0.05). The area under the ROC curves for SYN-1, LAC, and APACHE II scores in predicting 28-day mortality were 0.668, 0.641, and 0.666, respectively. SYN-1 showed a positive correlation with SOFA scores (correlation coefficient=0.228). SYN-1, APACHE II score, and LAC were identified as independent risk factors for 28-day mortality in sepsis patients. Conclusion: SYN-1 demonstrates high sensitivity and specificity in early prediction of poor outcomes in sepsis patients. SYN-1, APACHE II score, and LAC serve as independent risk factors for 28-day mortality in sepsis patients. Keywords: Syndecan-1, sepsis, septic shock Sepsis is characterized by a systemic inflammatory response syndrome that can lead to severe outcomes including multiple organ failure and shock. 1 Due to its rapid progression, severity, and high mortality rate, it is of utmost concern to clinicians. Early identification of sepsis severity and prognosis through effective detection methods is crucial for reducing mortality rates. 2 Various severity scoring systems have been studied extensively in critically ill patients, such as the Acute Physiological and Chronic Health Evaluation II (APACHE II) score, 3 Glasgow Coma Scale (GCS), 4 and the Sequential Organ Failure Assessment (SOFA) score. 5 However, the diverse etiologies of sepsis necessitate the exploration of novel biomarkers for assessing and stratifying patients at high risk. This research is essential for clinicians to facilitate precise treatment, prioritize surveillance efforts, and allocate resources effectively. Increasingly, biomarkers such as Syndecan-1 (SYN-1) are being utilized as early adjuncts in clinical settings. SYN-1 is a transmembrane proteoglycan cell adhesion molecule and a key member of the heparan sulfate proteoglycan family. It plays pivotal roles in various pathophysiological processes, including cell morphology maintenance, tissue repair promotion, immune function regulation, and host defense. 6 Notably, SYN-1 is crucial for stabilizing the intestinal epithelial barrier, serving as a vital protective mechanism. 7 This study focuses on assessing SYN-1 levels in sepsis patients to determine its clinical significance in predicting severity and 28-day mortality. This retrospective single-center observational study focused on critically ill patients admitted to the emergency department of Beijing Chao-Yang Hospital Shijingshan Branch between October 2020 and October 2021. A total of 215 patients were enrolled, with 168 patients included in the study. Due to the family's decision for palliative care, 47 patients were subsequently excluded from the study, with data collected on age, sex, vital signs, and comorbidities. Based on Sepsis 3.0 criteria, patients were categorized into the sepsis group (n=114) and septic shock group (n=54). The study received ethical approva -Abstract Truncated-
immunology